Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 10, 2021

SELL
$86.23 - $125.19 $610,939 - $886,971
-7,085 Closed
0 $0
Q4 2020

Feb 03, 2021

SELL
$79.17 - $111.47 $21,296 - $29,985
-269 Reduced 3.66%
7,085 $635,000
Q3 2020

Oct 27, 2020

SELL
$81.91 - $134.94 $104,189 - $171,643
-1,272 Reduced 14.75%
7,354 $760,000
Q2 2020

Jul 23, 2020

BUY
$54.33 - $89.52 $468,650 - $772,199
8,626 New
8,626 $682,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $414M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Lee Financial Group Hawaii, Inc. Portfolio

Follow Lee Financial Group Hawaii, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Financial Group Hawaii, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lee Financial Group Hawaii, Inc. with notifications on news.